Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity National Information Services
FIS
|
+$513M |
| 2 |
Medtronic
MDT
|
+$477M |
| 3 |
Apple
AAPL
|
+$403M |
| 4 |
L3Harris
LHX
|
+$334M |
| 5 |
Danaher
DHR
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$433M |
| 2 |
AbbVie
ABBV
|
+$350M |
| 3 |
LLL
L3 Technologies, Inc.
LLL
|
+$315M |
| 4 |
CoStar Group
CSGP
|
+$273M |
| 5 |
Abbott
ABT
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.77% |
| 2 | Healthcare | 16.13% |
| 3 | Financials | 12.76% |
| 4 | Industrials | 11.58% |
| 5 | Consumer Discretionary | 10.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
ICL Group
ICL
$6.65B
| $9.87M | 0.01% |
1,987,617
-1,403,504
| -41% | -$7M |
|
952
State Street
STT
$50.7B
| $9.8M | 0.01% |
165,589
+18,707
| +13% | +$1.04M |
|
953
Canadian Imperial Bank of Commerce
CM
$108B
| $9.76M | 0.01% |
236,394
-92,594
| -28% | -$3.64M |
|
954
BridgeBio Pharma
BBIO
$16.5B
| $9.71M | 0.01% |
452,171
+106,182
| +31% | +$2.94M |
|
955
Packaging Corp of America
PKG
$22.5B
| $9.7M | 0.01% |
91,452
+48,599
| +113% | +$4.92M |
|
956
Campbell Soup
CPB
$6.67B
| $9.64M | 0.01% |
205,395
+18,640
| +10% | +$805K |
|
957
D.R. Horton
DHI
$41.3B
| $9.59M | 0.01% |
181,846
+3,620
| +2% | +$173K |
|
958
The RealReal
REAL
$1.4B
| $9.56M | 0.01% |
427,393
-172,607
| -29% | -$3.47M |
|
959
Televisa
TV
$1.48B
| $9.54M | 0.01% |
975,085
+63,590
| +7% | +$575K |
|
960
Diamondback Energy
FANG
$55.1B
| $9.53M | 0.01% |
105,930
+16,595
| +19% | +$1.65M |
|
961
Bath & Body Works
BBWI
$4.13B
| $9.47M | 0.01% |
597,934
+498,013
| +498% | +$8.79M |
|
962
Credit Acceptance
CACC
$5.78B
| $9.4M | 0.01% |
20,377
-11,066
| -35% | -$5.23M |
|
|
GAP
963
The Gap Inc
GAP
$7.07B
| $9.38M | 0.01% |
540,645
-349,572
| -39% | -$6.21M |
|
964
Perrigo
PRGO
$1.4B
| $9.38M | 0.01% |
167,741
+48,070
| +40% | +$2.45M |
|
|
IGMS
965
DELISTED
IGM Biosciences
IGMS
| $9.35M | 0.01% |
+526,527
| New | +$10.6M |
|
966
Service Corp International
SCI
$11.4B
| $9.29M | 0.01% |
194,368
-46,112
| -19% | -$2.16M |
|
967
DXC Technology
DXC
$1.68B
| $9.2M | 0.01% |
311,769
+27,079
| +10% | +$1.15M |
|
968
Genpact
G
$5.45B
| $9.19M | 0.01% |
237,215
+73,669
| +45% | +$2.92M |
|
969
APA Corp
APA
$12.3B
| $9.13M | ﹤0.01% |
356,756
+76,013
| +27% | +$1.82M |
|
970
Devon Energy
DVN
$49.8B
| $9.13M | ﹤0.01% |
379,498
+139,800
| +58% | +$3.5M |
|
|
ZNGA
971
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $9.13M | ﹤0.01% |
1,567,895
+406,230
| +35% | +$2.44M |
|
972
Regency Centers
REG
$15.1B
| $9.12M | ﹤0.01% |
131,297
-103,103
| -44% | -$6.86M |
|
973
MGM Resorts International
MGM
$11.8B
| $9.04M | ﹤0.01% |
325,936
+48,458
| +17% | +$1.39M |
|
974
Assurant
AIZ
$13.7B
| $9.02M | ﹤0.01% |
71,695
+13,006
| +22% | +$1.54M |
|
975
Boston Properties
BXP
$11B
| $9.02M | ﹤0.01% |
69,524
+16,457
| +31% | +$2.14M |
|
Similar funds
Janus Henderson Group's Q3 2019 Portfolio in Review
As of Q3 2019, Janus Henderson Group held 1,465 positions worth $185B, up 0.14% from $184B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Janus Henderson Group's Q3 2019 filing shows 95 new, 675 increased, 602 reduced and 67 closed positions. Its largest new stake was Medtronic: 4,571,875 shares worth $497M. The largest sale was Mastercard, an estimated $433M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2019 buy was Medtronic: 4,571,875 shares worth $497M.
- Janus Henderson Group added most to Fidelity National Information Services in Q3 2019, an estimated $513M increase.
- Janus Henderson Group's biggest Q3 2019 reduction was Mastercard, cutting an estimated $433M.
- Janus Henderson Group fully exited L3 Technologies, Inc. in Q3 2019, selling an estimated $315M.
- Janus Henderson Group's ten largest holdings make up 17% of its $185B portfolio in Q3 2019.
- Janus Henderson Group opened 95 new positions and closed 67 in Q3 2019.
- Janus Henderson Group's portfolio value rose 0.14% quarter-over-quarter to $185B.
Based on Janus Henderson Group's 13F filing for Q3 2019, filed 14 Nov 2019.